Agenus to Acquire Privately Held 4-Antibody AG for $10M in Stock
January 13, 2014 at 07:11 AM EST
Agenus (NASDAQ: AGEN ) today announced that it has entered into a definitive agreement to acquire 4-Antibody AG, a private European-based biopharmaceutical company.
